Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial

Introduction Helicobacter pylori is a major health problem, with the high prevalence of H. pylori and the increasing antibiotic resistance rate in China. Antibiotic resistance is the main reason for the failure of H. pylori eradication. This study aims to evaluate the efficacy and safety of suscepti...

Full description

Saved in:
Bibliographic Details
Main Authors: Geliang Yang, Yi Cui, Shenke Zhang, Shuqin Hu, Sujuan Fei
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/12/e088788.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841536737673740288
author Geliang Yang
Yi Cui
Shenke Zhang
Shuqin Hu
Sujuan Fei
author_facet Geliang Yang
Yi Cui
Shenke Zhang
Shuqin Hu
Sujuan Fei
author_sort Geliang Yang
collection DOAJ
description Introduction Helicobacter pylori is a major health problem, with the high prevalence of H. pylori and the increasing antibiotic resistance rate in China. Antibiotic resistance is the main reason for the failure of H. pylori eradication. This study aims to evaluate the efficacy and safety of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR (qPCR) for H. pylori eradication.Methods and analysis This is a multicentre, open, randomised clinical trial that will enroll 324 patients with H. pylori infection. Patients will be randomised to two groups for a 14-day treatment: Treatment group will be treated with proton pump inhibitor (PPI), bismuth with two different kinds of antibiotics susceptibly guided by string test coupled with qPCR, while control group will be treated empirically with PPI, bismuth with two different kinds of antibiotics. The types and dosages of bismuth, PPI and antibiotics administered in this trial are based on the 2022 Chinese Guidelines for the treatment of H. pylori infection and the Sixth Chinese National Consensus Report on the management of H. pylori infection. The primary endpoint is the eradication rate, while secondary endpoints include compliance, the incidence of adverse events and adverse drug reactions.Ethics and dissemination This study was approved by the ethics committee of the Third People’s Hospital of Zhengzhou (No. 2024-04-001-K02). The results will be published in the appropriate peer-reviewed journal.Trial registration number ChiCTR2400082768.
format Article
id doaj-art-a726dcdfd9d54c538b827b806ae99183
institution Kabale University
issn 2044-6055
language English
publishDate 2024-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-a726dcdfd9d54c538b827b806ae991832025-01-14T11:40:11ZengBMJ Publishing GroupBMJ Open2044-60552024-12-01141210.1136/bmjopen-2024-088788Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trialGeliang Yang0Yi Cui1Shenke Zhang2Shuqin Hu3Sujuan Fei43 Department of Medicine, Shanghai Clinical Research Center, Shanghai, China1 Department of Gastroenterology, The Third People`s Hospital of Zhengzhou, Zhengzhou, Henan, China2 Marshall Laboratory of Biomedical Engineering, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, Guangdong, China3 Department of Medicine, Shanghai Clinical Research Center, Shanghai, China4 Department of Gastroenterology, Xuzhou Medical University Affiliated Hospital, Xuzhou, Jiangsu, ChinaIntroduction Helicobacter pylori is a major health problem, with the high prevalence of H. pylori and the increasing antibiotic resistance rate in China. Antibiotic resistance is the main reason for the failure of H. pylori eradication. This study aims to evaluate the efficacy and safety of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR (qPCR) for H. pylori eradication.Methods and analysis This is a multicentre, open, randomised clinical trial that will enroll 324 patients with H. pylori infection. Patients will be randomised to two groups for a 14-day treatment: Treatment group will be treated with proton pump inhibitor (PPI), bismuth with two different kinds of antibiotics susceptibly guided by string test coupled with qPCR, while control group will be treated empirically with PPI, bismuth with two different kinds of antibiotics. The types and dosages of bismuth, PPI and antibiotics administered in this trial are based on the 2022 Chinese Guidelines for the treatment of H. pylori infection and the Sixth Chinese National Consensus Report on the management of H. pylori infection. The primary endpoint is the eradication rate, while secondary endpoints include compliance, the incidence of adverse events and adverse drug reactions.Ethics and dissemination This study was approved by the ethics committee of the Third People’s Hospital of Zhengzhou (No. 2024-04-001-K02). The results will be published in the appropriate peer-reviewed journal.Trial registration number ChiCTR2400082768.https://bmjopen.bmj.com/content/14/12/e088788.full
spellingShingle Geliang Yang
Yi Cui
Shenke Zhang
Shuqin Hu
Sujuan Fei
Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial
BMJ Open
title Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial
title_full Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial
title_fullStr Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial
title_full_unstemmed Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial
title_short Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial
title_sort efficacy of susceptibility guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative pcr for helicobacter pylori eradication a protocol of a multicentre open randomised clinical trial
url https://bmjopen.bmj.com/content/14/12/e088788.full
work_keys_str_mv AT geliangyang efficacyofsusceptibilityguidedquadrupletherapywithantibioticresistanceusingthestringtestcoupledwithquantitativepcrforhelicobacterpylorieradicationaprotocolofamulticentreopenrandomisedclinicaltrial
AT yicui efficacyofsusceptibilityguidedquadrupletherapywithantibioticresistanceusingthestringtestcoupledwithquantitativepcrforhelicobacterpylorieradicationaprotocolofamulticentreopenrandomisedclinicaltrial
AT shenkezhang efficacyofsusceptibilityguidedquadrupletherapywithantibioticresistanceusingthestringtestcoupledwithquantitativepcrforhelicobacterpylorieradicationaprotocolofamulticentreopenrandomisedclinicaltrial
AT shuqinhu efficacyofsusceptibilityguidedquadrupletherapywithantibioticresistanceusingthestringtestcoupledwithquantitativepcrforhelicobacterpylorieradicationaprotocolofamulticentreopenrandomisedclinicaltrial
AT sujuanfei efficacyofsusceptibilityguidedquadrupletherapywithantibioticresistanceusingthestringtestcoupledwithquantitativepcrforhelicobacterpylorieradicationaprotocolofamulticentreopenrandomisedclinicaltrial